Trials / Completed
CompletedNCT03263481
Intraductal Secretin Stimulation Test: What Is the Proper Collection Time?
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- Indiana University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim is to evaluate the peak secretory flow rates and bicarbonate concentrations as determined by a 30 minute intraductal secretin stimulation test in patients with a low likelihood of pancreatic pathology and to compare these data to those obtained from our historical patients with suspected chronic pancreatitis. These will be patients in which inadvertent pancreatic cannulation occurs during therapeutic endoscopic retrograde cholangiopancreatography (ERCP) for biliary indications . All study subjects will receive a 5 day follow-up phone call. Enrollment goal is 36 subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Intraductal secretin test (IDST) | If pancreatic duct entry incidentally occurs during the clinically scheduled ERCP and the pancreatic duct appears normal, an IDST will be performed for study purposes. An IDST consists of the administration of human secretin, after which pancreatic juice is collected intraductally. In this study, the fluid will be collected through continuous aspiration in 5 minute intervals for 30 minutes. Samples will be collected at 5, 10, 15, 20, 25, and 30 minutes after secretin administration (6 collections in total). |
Timeline
- Start date
- 2017-09-01
- Primary completion
- 2023-09-01
- Completion
- 2023-09-01
- First posted
- 2017-08-28
- Last updated
- 2023-09-22
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03263481. Inclusion in this directory is not an endorsement.